---
schema_version: "secwatch.filing_event.v1"
accession: "0001723128-22-000023"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2022-06-02T23:59:59+00:00"
generated_at: "2026-06-25T05:11:01.669295+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Amneal refinances $500M credit facility with new $350M revolving facility maturing 2027

## Summary
- New $350M senior secured revolving credit facility with Truist Bank as administrative agent; matures June 2, 2027.
- Interest rates: ABR + 0.25% to 0.50% or SOFR + 1.25% to 1.50% per annum, depending on excess availability.
- Includes $25M letter of credit subfacility and $35M swingline; incremental increase option up to $150M.
- Prior $500M facility (due May 2023) terminated with no outstanding amounts and no termination penalties incurred.
- Proceeds may be used for capex, acquisitions, working capital, and general purposes under customary negative covenants.

## SEC filing metadata
- accession: 0001723128-22-000023
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2022-06-02T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000172312822000023/0001723128-22-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000172312822000023/amrx-20220602.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001723128-22-000023
- JSON: https://secwatch.observer/filing/0001723128-22-000023.json
- Plain text: https://secwatch.observer/filing/0001723128-22-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.